Sort
8,912 grants matching “sars cov 2”
Programming Long-lasting Immunity to Coronaviruses (PLUTO)
$2,494,973Viviana A Simon · Icahn School Of Medicine At Mount Sinai · P01 · FY2024 · AI
Programming Long-lasting Immunity to Coronaviruses (PLUTO)
$2,494,973Viviana A Simon · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · AI
Clinical Core
$2,490,548Gabriel Alejandro De Erausquin · University Of Texas Hlth Science Center · U19 · FY2023 · AG
HPMI: Host Pathogen Mapping Initiative
$2,489,172Nevan J Krogan · University Of California, San Francisco · U19 · FY2023 · AI
mAbs and vaccines against SARS CoV-2
$2,487,506Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
RFA-IP-22-004, CORVETS - Cleveland Ohio Respiratory Viruses Vaccines Effectiveness across Traditional Risk Factors and Social Determinants of Health
$2,484,354Elie Saade · University Hospitals Of Cleveland · U01 · FY2022 · IP
RFA-IP-22-004, Multidisciplinary Approach to Understanding Vaccine Efficacy and Transmission of Viral Respiratory Tract Infections in the Real World
$2,483,947Stacey House · Washington University · U01 · FY2022 · IP
Pre-clinical Vaccine Development for Emerging and Re-emerging Infectious Diseases
$2,480,852Wing Pui Kong · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
Pre-clinical Vaccine Development for Emerging and Re-emerging Infectious Diseases
$2,480,852Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIC · FY2022 · AI
HPMI: Host Pathogen Mapping Initiative
$2,475,950Nevan J Krogan · University Of California, San Francisco · U19 · FY2024 · AI
Core 2: Biocontainment and Immune Monitoring Core
$2,468,103Gregory D Sempowski · Duke University · P01 · FY2021 · AI
HPMI: Host Pathogen Mapping Initiative
$2,464,183Nevan J Krogan · University Of California, San Francisco · U19 · FY2025 · AI
COVID-19 Clinical Support and Research
$2,457,478Adrian McDermott · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Genetics and Epigenetics of Cardiovascular Disease
$2,457,031Gary Gibbons · National Human Genome Research Institute · ZIA · FY2023 · HG
NIH StrokeNet National Clinical Coordinating Center (NCC)
$2,455,413Joseph Paul Broderick · University Of Cincinnati · U01 · FY2025 · NS
Optimizing SARS-CoV-2 wastewater based surveillance in urban and university campus settings.
$2,448,262Anne-Catrin Uhlemann · Columbia University Health Sciences · U01 · FY2021 · DA
An integrative structural biology approach to understanding metabolite recognition by cellular receptors
$2,447,500Nikolaos Sgourakis · Children'S Hosp Of Philadelphia · R35 · FY2025 · GM
Durable Alteration of the Human Immune system after Infection or Immunotherapy
$2,446,152Raymond T Chung · Massachusetts General Hospital · U19 · FY2024 · AI
SARS-CoV adaptations through a Systems Biology Lens (SYBIL)
$2,445,345Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2025 · AI
THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION PERIOD 2 BY ADDING ADDING COVID-19 FUNDS FOR THE PERIOD OF PERFORMANCE OF 1/1/21 TO 4/30/21.
$2,444,259Mark Marino · Venturewell · N02 · FY2021 · HL
Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases
$2,442,797Hong-Wei Sun · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2024 · AR
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross
$2,437,629Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2017 · AI
IMmunoPhenotyping Assessment in a COVID-19 Cohort (IMPACC): Clinical and Data Coordinating Center (CDCC)
$2,426,447Ofer Levy · Boston Children'S Hospital · U19 · FY2020 · AI
Clinical and Data Coordinating Center (CDCC)]
$2,426,447Ofer Levy · Boston Children'S Hospital · U19 · FY2020 · AI
Immune Cells and Secretory Pathways Leading to Human Systemic Autoimmunity
$2,419,315Maria Virginia Pascual · Weill Medical Coll Of Cornell Univ · U19 · FY2020 · AI